Acurx Pharmaceuticals Inc

NASDAQ:ACXP   3:59:55 PM EDT
2.69
+0.17 (+6.75%)
Earnings Announcements

Acurx Pharmaceuticals Reports Q4, Full Year 2021 Results And Provides Business Update

Published: 03/17/2022 11:14 GMT
Acurx Pharmaceuticals Inc (ACXP) - Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.